Summary of significant accounting policies (Details) - Schedule of expense related to share-based payment arrangements - USD ($) $ in Thousands |
12 Months Ended | ||
---|---|---|---|
Jul. 31, 2020 |
Jul. 31, 2019 |
Jul. 31, 2018 |
|
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | $ 933 | $ 939 | $ 813 |
Cost of clinical laboratory services [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | 46 | ||
Selling, general and administrative [Member] | |||
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items] | |||
Share Based Compensation | $ 887 | $ 939 | $ 813 |
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Amount of noncash expense for share-based payment arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|